Naylor ML, Yun J, Arnold D. No evidence of disease activity achievement over 4 years of peginterferon beta-1a treatment in newly diagnosed patients with relapsing Multiple Sclerosis: subgroup analyses of ADVANCE/ATTAIN. EAN 2018, poster EPR2116.
Het Neurologisch Jaaroverzicht 2019
feb 2020 | Bewegingsstoornissen, Dementie, Hoofdpijn, Multipele Sclerose